sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , trojna kombinacija terapija), kot dodatek k prehrani in vadbi pri bolnikih neustrezno nadzorovano na maksimalno dopustne odmerek metforminom in sulfonil sečnine. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , trojna kombinacija terapija), kot dodatek k prehrani in vadbi pri bolnikih neustrezno nadzorovano na maksimalno dopustne odmerek metforminom in sulfonil sečnine. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
siofor 1000 mg filmsko obložene tablete
laboratori guidotti s.p.a. - metformin - filmsko obložena tableta - metformin 780 mg / 1 tableta - metformin
siofor 1000 mg filmsko obložene tablete
laboratori guidotti s.p.a. - metformin - filmsko obložena tableta - metformin 780 mg / 1 tableta - metformin
aglurab 850 mg filmsko obložene tablete
medis, d.o.o. - metformin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta - metformin
aglurab 850 mg filmsko obložene tablete
medis, d.o.o. - metformin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta - metformin
aglurab 500 mg filmsko obložene tablete
medis, d.o.o. - metformin - filmsko obložena tableta - metformin 390 mg / 1 tableta - metformin
aglurab 1000 mg filmsko obložene tablete
medis, d.o.o. - metformin - filmsko obložena tableta - metformin 780 mg / 1 tableta - metformin
glucophage 1000 mg filmsko obložene tablete
merck d.o.o. - metformin - filmsko obložena tableta - metformin 780 mg / 1 tableta - metformin
glucophage 500 mg filmsko obložene tablete
merck d.o.o. - metformin - filmsko obložena tableta - metformin 390 mg / 1 tableta - metformin